Clinical Trial Update: The Role of Ovarian PRP Therapy in Poseidon Poor Responders Women Undergoing ICSI Cycle [NA]

View source ↗

Summary

A completed clinical trial evaluating platelet-rich plasma therapy for poor ovarian reserve in women undergoing ICSI.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Poor Ovarian Reserve

Drugs mentioned

• Platelet-rich plasma therapy (platelet-rich plasma)

Snippet

Sponsor: Karbala University | Conditions: Poor Ovarian Reserve, Platelet Derived Growth Factor | NA | Status: COMPLETED